Table 3

Incidence rate of MACEs for patients with hyperglycaemic crisis, stratified by age and sex

Variables	Hyperglycaemic crisis						Crude HR	Adjusted HR
	No			Yes
	(N=8684)			(N=2171)
	Event	Person-years	IR†	Event	Person-years	IR†	(95% CI)	(95% CI)
Total	2100	44 228	47.48	676	8565	78.93	1.65 (1.51 to 1.80)***	1.76 (1.62 to 1.92)***
Sex‡
Female	908	20 336	44.65	333	3992	83.41	1.85 (1.63 to 2.1)***	1.89 (1.67 to 2.15)***
Male	1192	23 892	49.89	343	4573	75.01	1.49 (1.32 to 1.68)***	1.66 (1.47 to 1.88)***
Age§
20–39	47	6042	7.78	31	1472	21.06	2.69 (1.71 to 4.24)***	2.60 (1.63 to 4.16)***
40–64	884	25 691	34.41	321	4938	65.00	1.89 (1.66 to 2.15)***	1.96 (1.72 to 2.22)***
≥65	1169	12 495	93.56	324	2155	150.37	1.58 (1.40 to 1.79)***	1.57 (1.39 to 1.78)***

Adjusted HR: adjusted for hyperglycaemic crisis, age, sex, socioeconomic status, comorbidity and medications.
†Per 1000 person-years.
‡Adjusted for all covariates in the full model except sex.
§Adjusted for all covariates in the full model except age.
IR, incidence rates; MACE, major adverse cardiovascular events.